KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Deferred Taxes (2016 - 2026)

Medtronic's Deferred Taxes history spans 13 years, with the latest figure at -$101.0 million for Q1 2026.

  • For Q1 2026, Deferred Taxes rose 26.81% year-over-year to -$101.0 million; the TTM value through Jan 2026 reached -$176.0 million, up 48.08%, while the annual FY2025 figure was -$316.0 million, 37.8% up from the prior year.
  • Deferred Taxes for Q1 2026 was -$101.0 million at Medtronic, down from -$7.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $167.0 million in Q3 2025 and bottomed at -$370.0 million in Q2 2022.
  • The 5-year median for Deferred Taxes is -$87.5 million (2022), against an average of -$94.8 million.
  • The largest annual shift saw Deferred Taxes skyrocketed 108.97% in 2023 before it plummeted 1628.57% in 2024.
  • A 5-year view of Deferred Taxes shows it stood at -$74.0 million in 2022, then skyrocketed by 51.35% to -$36.0 million in 2023, then rose by 13.89% to -$31.0 million in 2024, then skyrocketed by 77.42% to -$7.0 million in 2025, then tumbled by 1342.86% to -$101.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Deferred Taxes are -$101.0 million (Q1 2026), -$7.0 million (Q4 2025), and $167.0 million (Q3 2025).